Clinical trial
CD19-STAR-T for Patients With B Cell Malignancies
NCT03953599 is registered in ClinicalTrials.gov with Hebei Yanda Ludaopei Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CD19-STAR-T for Patients With B Cell Malignancies
- Lead sponsor
- Hebei Yanda Ludaopei Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 1, 2019
- Completion date
- December 31, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
b cell malignancy